Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Cipla
US Army
Chubb
Argus Health
Covington
Mallinckrodt
Cantor Fitzgerald
Johnson and Johnson

Generated: July 22, 2018

DrugPatentWatch Database Preview

Hydroflumethiazide - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for hydroflumethiazide and what is the scope of hydroflumethiazide freedom to operate?

Hydroflumethiazide
is the generic ingredient in seven branded drugs marketed by Wyeth Ayerst, Par Pharm, Watson Labs, Shire Llc, Usl Pharma, Ivax Pharms, and Shire, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for hydroflumethiazide.
Summary for hydroflumethiazide
Medical Subject Heading (MeSH) Categories for hydroflumethiazide
Synonyms for hydroflumethiazide
1,1-bis(oxidanylidene)-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1,1-DIOXO-6-(TRIFLUOROMETHYL)-1,2,3,4-TETRAHYDRO-1L-6-2-4-BENZATHIADIAZINE-7-SULFONAMIDE
1,1-Dioxo-6-(trifluoromethyl)-1,2,3,4-tetrahydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1?^{6},2,4-benzothiadiazine-7-sulfonamide
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-1$l;{6},2,4-benzothiadiazine-7-sulfonamide
1,1-dioxo-6-(trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide
135-09-1
2H-1,2, 4-Benzothiadiazine-7-sulfonamide, 3, 4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide
2H-1,4-Benzothiadiazine-7-sulfonamide, 3,4-dihydro-6-(trifluoromethyl)-, 1,1-dioxide
3, 4-Dihydro-6-trifluorom
3, 4-Dihydro-6-trifluoromethyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3, 4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1, 1-dioxide
3,2,4-benzothiadiazine 1,1-dioxide
3,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3,2,4-thiadiazine 1,1-dioxide
3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide
3,4-Dihydro-6-(trifluoromethyl)-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide
3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7-sulphonamide-1,1-dioxide
3,4-Dihydro-6-trifluoromethyl-2H-1,2,4-benzothiadiazine-7sulphonamide-1,1-dioxide
3,4-Dihydro-6-trifluoromethyl-7-sulfamoylbenzo-1,2,4-thiadiazine 1,1-dioxide
3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2, 4-benzothi
3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2, 4-benzothiadiazine 1,1-dioxide
3,4-Dihydro-7-sulfamoyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
3,4-Dihydro-7-sulfamyl-6-trifluoromethyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
4-27-00-08035 (Beilstein Handbook Reference)
501CFL162R
6-(Trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide
6-(Trifluoromethyl)-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide #
6-(Trifluoromethyl)-3,4-dihydro-2H-benzo-[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
6-(Trifluoromethyl)-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide
6-Trifluoromethyl-3, 4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
6-Trifluoromethyl-3,2,4-benzothiadiazine 1,1-dioxide
6-Trifluoromethyl-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide
6-Trifluoromethyl-7-sulfamoyl-3,2,4-benzothiadiazine-1,1-dioxide
6-Trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2, 4-benzothiadiazine-1,1-dioxide
6-Trifluoromethyl-7-sulfamoyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
6-Trifluoromethyl-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide
6273AA
7-Sulfamoyl-6-tri
7-Sulfamoyl-6-trifluoromethyl-3, 4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
7-Sulfamoyl-6-trifluoromethyl-3,2,4-benzothiadiazine 1,1-dioxide
7-Sulfamoyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1, 1-dioxide
7-Sulfamyl-6-trifluoromethyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
A806882
AB00052016
AB00052016_15
AC1L1GEH
AC1Q4JYO
adiazine 1,1-dioxide
AJ-24271
AK-58361
AKOS015913797
ANW-72013
AX8006313
BDBM25897
BMCL182567 Compound 6b
BPBio1_000051
BRD-K36862742-001-05-8
Bristab
Bristurin
BRN 0342692
BSPBio_000045
BSPBio_002140
C-20051
C07763
C8H8F3N3O4S2
CAS-135-09-1
CC-13172
CCG-40228
CHEBI:5784
CHEMBL1763
cid_3647
component of Salutensin
CPD000058284
CTK8C4452
D00654
D00WAM
DB-042267
DB00774
Di-ademil
Di-adenil
Dihydroflumethazide
Dihydroflumethiazide
Diucardin
Diuredemina
Diurometon
DivK1c_000512
DMDGGSIALPNSEE-UHFFFAOYSA-N
DSSTox_CID_3132
DSSTox_GSID_23132
DSSTox_RID_76886
DTXSID3023132
EINECS 205-173-8
Elodrin
Elodrine
Enjit
ethyl-2H-1,2, 4-benzothiadiazine-7-sulfonamide 1,1-dioxide
Finuret
fluoromethyl-3, 4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide
Flutizide
FT-0614319
Glomerulin
GTPL7197
HE004789
HE307697
Hidroalogen
Hidroflumetiazid
Hidroflumetiazida
Hidroflumetiazida [INN-Spanish]
HMS1568C07
HMS1920F05
HMS2091L13
HMS2095C07
HMS2235E09
HMS3259C15
HMS3371H03
HMS501J14
HSDB 3340
Hydol
Hydrenox
Hydroflumethazide
Hydroflumethiazide (JAN/USP/INN)
Hydroflumethiazide [INN:BAN:JAN]
Hydroflumethiazide [USP:INN:BAN:JAN]
Hydroflumethiazide, analytical standard, ~97%
Hydroflumethiazide, United States Pharmacopeia (USP) Reference Standard
Hydroflumethiazidum
Hydroflumethiazidum [INN-Latin]
Hydroflumethizide
I14-45008
IDI1_000512
Idroflumetiazide
Idroflumetiazide [DCIT]
J-006640
KB-82360
KBio1_000512
KBio2_001385
KBio2_003953
KBio2_006521
KBio3_001360
KBioGR_000359
KBioSS_001385
Leodrine
LS-40451
MCULE-8204847370
Metflorylthiazidine
Metforylthiadiazin
Metforylthiazidin
Methforylthiazidine
MFCD00057316
MLS000028516
MLS001148090
MolPort-001-771-232
Naciex (glaxo)
NaClex
NC00496
NCGC00016401-01
NCGC00016401-02
NCGC00016401-03
NCGC00016401-04
NCGC00016401-05
NCGC00016401-06
NCGC00016401-09
NCGC00023353-03
NCGC00023353-04
NINDS_000512
NSC 44627
NSC-44627
NSC-757071
NSC44627
NSC757071
Olmagran
Opera_ID_326
PC0903
Pharmakon1600-01500341
Prestwick_268
Prestwick0_000013
Prestwick1_000013
Prestwick2_000013
Prestwick3_000013
River
Rivosil
Robezon
Rodiuran
Rontyl
Saluron
Saluron (TN)
SAM002703134
SB01887
SBI-0051411.P003
SCHEMBL27028
Sisuril
SMR000058284
Spandiuril
SPBio_001139
SPBio_001966
Spectrum_000905
SPECTRUM1500341
Spectrum2_001010
Spectrum3_000460
Spectrum4_000010
Spectrum5_000832
SR-01000003094
SR-01000003094-2
SR-01000003094-3
TC-160758
Tox21_110422
Tox21_110422_1
Trifluoromethylhydrazide
Trifluoromethylhydrothiazide
UNII-501CFL162R
Vergonil
VZ25545
WLN: T66 BSWM EM DHJ HXFFF ISZW
ZB015131
ZINC897225
ZX-AP007542

US Patents and Regulatory Information for hydroflumethiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs HYDROFLUMETHIAZIDE AND RESERPINE hydroflumethiazide; reserpine TABLET;ORAL 088110-001 Mar 22, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Watson Labs HYDROFLUMETHIAZIDE hydroflumethiazide TABLET;ORAL 088031-001 Apr 6, 1983 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm HYDROFLUMETHIAZIDE hydroflumethiazide TABLET;ORAL 088850-001 May 31, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm RESERPINE AND HYDROFLUMETHIAZIDE hydroflumethiazide; reserpine TABLET;ORAL 088907-001 Sep 20, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Federal Trade Commission
US Department of Justice
US Army
QuintilesIMS
Dow
Baxter
Julphar
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.